Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Eva Rye Rasmussen"'
Publikováno v:
Archives of Clinical and Experimental Surgery, Vol 6, Iss 3, Pp 120-125 (2017)
Objective: Ketorolac is a non-steroid anti-inflammatory drug for intravenous use, with analgesic and anti-inflammatory effects and known for its potent influence on moderate to severe postoperative pain. The literature has shown that 30mg i.v. periop
Externí odkaz:
https://doaj.org/article/275356b704244595b41ff159db3d6c60
Autor:
Haivin Aziz Ali, Anne Fog Lomholt, Seyed Hamidreza Mahmoudpour, Thorbjørn Hermanrud, Anette Bygum, Christian von Buchwald, Marianne Antonius Jakobsen, Eva Rye Rasmussen
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0227056 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0224858.].
Externí odkaz:
https://doaj.org/article/11550a5fcebb48c6a4afaaa687e2e620
Autor:
Haivin Aziz Ali, Anne Fog Lomholt, Seyed Hamidreza Mahmoudpour, Thorbjørn Hermanrud, Anette Bygum, Christian von Buchwald, Marianne Antonius Jakobsen, Eva Rye Rasmussen
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224858 (2019)
Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II which causes vasoconstriction. ACE inhibitors reduce blood pressure by inhibiting ACE. A well-known adverse drug reaction to ACE inhibitors is ACE inhibitor-induced angioede
Externí odkaz:
https://doaj.org/article/1837de91b9dc41d19524a20c8ed8f27d
Publikováno v:
Ear and hearing.
This study investigated age at implantation, improvement in hearing and speech perception outcomes, as well as surgical complications in pediatric cochlear implant recipients with Pendred Syndrome (PS) or non-syndromic enlarged vestibular aqueduct (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d4a4019e17579c0ab0891849a68baa
https://pubmed.ncbi.nlm.nih.gov/36397213
https://pubmed.ncbi.nlm.nih.gov/36397213
Autor:
Gustav Ahlberg, Henrik Ullum, Oscar Petersen, Eva Rye Rasmussen, Michael Schwinn, Karina Banasik, Erik Sørensen, Morten S. Olesen, Søren Brunak, Mia Wadelius, Ina Holst Larsen, Niclas Eriksson, Pär Hallberg, Henning Bundgaard, Laura Andreasen, Jonas Ghouse
Publikováno v:
Journal of the American College of Cardiology. 78:696-709
Background Angioedema is a rare but potentially life-threatening adverse reaction associated with angiotensin-converting enzyme (ACE) inhibitors. Identification of potential genetic factor...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79696957c7b49766fd7ae7caa357409a
https://doi.org/10.1016/j.jacc.2021.05.054
https://doi.org/10.1016/j.jacc.2021.05.054
Publikováno v:
Case Reports in Emergency Medicine, Vol 2016 (2016)
Angioedema of the upper airways is a severe and potentially life-threatening condition. The incidence has been increasing in the past two decades, primarily due to pharmaceuticals influencing the generation or degradation of the vasoactive molecule b
Externí odkaz:
https://doaj.org/article/ad64d321970e4891b1cb4bc0e7fc9705
Publikováno v:
Drug, Healthcare and Patient Safety. 11:105-113
Purpose The primary objective of this study was to calculate the report rate of angiotensin-converting enzyme inhibitor-related angioedema (ACEi-AE). Secondary objectives were to determine factors suspected to affect the likelihood of ACEi-AE being r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40613679333d101d0f775c7c5bd8be81
https://doi.org/10.2147/dhps.s205119
https://doi.org/10.2147/dhps.s205119
Publikováno v:
Pharmacogenomics. 22(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5561b07310b91d73050a02cf399645
https://pubmed.ncbi.nlm.nih.gov/33849279
https://pubmed.ncbi.nlm.nih.gov/33849279
Autor:
Jonas, Ghouse, Gustav, Ahlberg, Laura, Andreasen, Karina, Banasik, Søren, Brunak, Michael, Schwinn, Ina Holst, Larsen, Oscar, Petersen, Erik, Sørensen, Henrik, Ullum, Eva Rye, Rasmussen, Niclas, Eriksson, Pär, Hallberg, Mia, Wadelius, Henning, Bundgaard, Morten S, Olesen
Publikováno v:
Journal of the American College of Cardiology. 78(7)
Angioedema is a rare but potentially life-threatening adverse reaction associated with angiotensin-converting enzyme (ACE) inhibitors. Identification of potential genetic factors related to this adverse event may help identify at-risk patients.The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1425a07892467224ca0fcaaadf643d4f
https://pubmed.ncbi.nlm.nih.gov/34384553
https://pubmed.ncbi.nlm.nih.gov/34384553
Autor:
Søren Brunak, Jonas Ghouse, Karina Banasik, Eva Rye Rasmussen, Mia Wadelius, Gustav Ahlberg, Laura Andreasen, Erik Sørensen, Pär Hallberg, Ina Holst Larsen, Henrik Ullum, Henning Bundgaard, Oscar Petersen, Michael Schwinn, Morten S. Olesen, Niclas Eriksson
ObjectiveAngioedema is a rare, but potentially life-threatening adverse reaction, associated with angiotensin-converting-enzyme inhibitors (ACEi). Identification of potential genetic factors related to this adverse event may help identify at-risk pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6df72601fca3eb4423bbbb275823c201
https://doi.org/10.1101/2020.12.10.20246967
https://doi.org/10.1101/2020.12.10.20246967
